AI Diagnostic Applications Showcased at AMP 2025 Annual Meeting
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read MorePosted by CLP Edit Staff | Nov 14, 2025 | Molecular Diagnostics |
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read MorePosted by CLP Edit Staff | Sep 30, 2025 | Quality Control Programs |
Performance and Diagnostics Insights platform provides comparative analytics to help labs optimize operations and improve patient care.
Read MorePosted by CLP Edit Staff | Sep 23, 2025 | Leukemia |
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 22, 2025 | Leukemia |
MARLIN uses DNA methylation patterns and machine learning to classify leukemia subtypes, potentially accelerating treatment decisions.
Read MorePosted by CLP Edit Staff | Aug 15, 2025 | Cancer |
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read More